About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Taking Aspirin Along With Celebrex can Decrease Its Cardiac Benefits

by Rishika Gupta on April 18, 2018 at 11:53 AM
Font : A-A+

Taking Aspirin Along With Celebrex can Decrease Its Cardiac Benefits

When aspirin was combined with celecoxib, the drug associated with cardiovascular safety and its effectiveness seems to have been reduced in the study. The findings of this study are published in the Journal of the American College of Cardiology.

A new substudy analyzed outcomes in PRECISION based on the presence or absence of aspirin use with specific NSAIDs (nonsteroidal anti-inflammatory drugs). The research shows that taking aspirin with celecoxib lessened its cardiovascular safety advantage, although it was still associated with fewer GI problems than either of the other drugs and fewer kidney issues than ibuprofen.

Advertisement


The decade-long PRECISION trial - Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen or Naproxen - studied osteoarthritis or rheumatoid arthritis patients who required the daily prescription use of NSAIDs for pain relief. All participants had pre-existing heart disease or increased risk for developing heart disease.

The researchers reviewed occurrences of major adverse cardiovascular events such as heart attack or stroke, noncardiovascular death, clinically significant GI events, anemia of GI origin or serious renal events. GI problems including ulcers or chronic bleeding are known complications of NSAIDs, and NSAIDs are also known to cause kidney complications.
Advertisement

The substudy followed nearly 24,000 patients with osteoarthritis or rheumatoid arthritis who were taking daily prescription doses of either celecoxib, naproxen or ibuprofen for a minimum of 18 months. Of those patients, 11,000 were also taking aspirin. Adding aspirin diminished some of the safety advantages for celecoxib that was observed in the PRECISION trial - as patients taking both had more of a risk for major adverse events compared to those on just celecoxib alone.

However, even with aspirin, celecoxib patients still had slightly less overall adverse outcomes than those taking ibuprofen with aspirin (6 percent vs. 7.1 percent). There was not a significant overall difference between celecoxib and naproxen with aspirin. In addition, celecoxib patients had fewer GI problems than ibuprofen (0.9 percent vs. 1.4 percent) or naproxen (1.6 percent) and fewer renal issues than ibuprofen (0.6 percent vs. 1.2 percent).

"NSAIDs are some of the most widely used drugs in the world with more than 100 million prescriptions issued annually in the United States. Past studies have reported conflicting results regarding using NSAIDs together with aspirin, but we know that many patients do combine the medications, so it was vital to understand the risks and differences among the drugs," said Steve Nissen, M.D., chairman of Cardiovascular Medicine at Cleveland Clinic, and the study's principle investigator.

"The outcomes of this study could lead to changes in clinical practice. If a patient is not on aspirin, these results suggest that in many cases, celecoxib may be the NSAID of choice," said Grant Reed, M.D., an interventional cardiology fellow at Cleveland Clinic, and the study's first author. "Our findings underscore how important it is that physicians counsel their patients when starting them on an NSAID and consider the potential effects of use together with aspirin."

The PRECISION trial was initiated following the withdrawal of rofecoxib (Vioxx) - a drug in the same class as celecoxib that worked similarly - from the market in 2004. The FDA mandated a clinical trial to determine if celecoxib shared a similar increased risk of heart-related complications.

PRECISION, known as a non-inferiority trial, demonstrated celecoxib is not more risky than the other two drugs, which are older and work in a different way. The primary outcomes of heart attack, stroke or death occurred in 2.3 percent of patients taking celecoxib, 2.5 percent of patients taking naproxen, and 2.7 percent of patients taking ibuprofen.

PRECISION also assessed a broader measure of cardiovascular safety - the primary outcome plus hospitalization for unstable angina or coronary revascularization (stenting or bypass) - and showed a 15 percent higher risk for ibuprofen than celecoxib, but this difference was borderline in statistical significance.

The PRECISION trial also assessed GI and renal complications. GI problems including ulcers or chronic bleeding are known complications of NSAIDs. Celecoxib and rofecoxib were introduced in 1999 as a new type of NSAID designed to reduce the risk of GI complications. In the PRECISION trial, the rate of ulcers or GI bleeding was 54 percent higher for ibuprofen, and 41 percent higher for naproxen than celecoxib.

NSAIDs are also known to cause kidney complications, and the trial showed a statistically significant 64 percent higher risk of worsening kidney function for ibuprofen compared with celecoxib. Numerically more kidney complications occurred with naproxen, but the difference was not statistically significant. Death from any cause was approximately 25 percent higher with naproxen than celecoxib, but this difference was borderline in statistical significance.

Osteoarthritis is the most common form of arthritis affecting more than 16 million Americans. Rheumatoid arthritis is a type of chronic arthritis that is an autoimmune disease affecting joints on both sides of the body. Rheumatoid arthritis is 2.5 times more common in women than men and affects more than 1.3 million people in the United States. Patients with rheumatoid arthritis are at an increased risk for heart disease. In the trial, 90 percent of patients had osteoarthritis, and 10 percent had rheumatoid arthritis.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Turmeric: Magic Ingredient to Keep you Healthy in Winter
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Palpitations And Arrhythmias Chemotherapy Chemotherapy Drugs Statins Anticoagulants Healthy Living Reye’s Syndrome Cardiomyopathy Colon Polyps 

Recommended Reading
Randomized Placebo Controlled Trial To Assess Role Of Low Dose Aspirin In Venous Ulceration
New randomized placebo controlled trial studies role of low dose aspirin as adjuvant in venous ......
No Aspirin, Brufen Sale Without Prescription in Delhi in the Wake of Rising Dengue Cases
People take medicines without consulting doctors, increasing the chances of bleeding in dengue ......
Stopping Daily Aspirin Therapy can Cause a Second Heart Attack
Stopping of long term low dose Aspirin therapy can increase the risk of cardiovascular events by ......
After Surgery, Aspirin Triggered Resolvin Protects Against Cognitive Decline
Resolvins are molecules naturally produced by the body from omega-3 fatty acids. This is a process ....
Anticoagulants
Anticoagulants prevent the clotting of blood in our body. They are administered orally or via ......
Cardiomyopathy
Cardiomyopathy weakens the heart muscles and the heart loses strength to pump blood throughout the b...
Chemotherapy
‘Chemo’ means medicine or ‘drug’; ‘therapy’ means ‘treatment’. Chemotherapy refers to the use of cy...
Chemotherapy Drugs
Chemotherapy drugs perform like ‘magic bullets’ to destroy cancer cells in the body....
Colon Polyps
A colon polyp is a fleshy growth on the inside of the colon, also called the large intestine. In gen...
Palpitations And Arrhythmias
Palpitations are unpleasant sensation of one’s own heartbeat....
Reye’s Syndrome
Reye's syndrome is a medical emergency chiefly affecting children and teenagers and is marked by the...
Statins
Statins are new wonder drugs that are proving to be efficacious, not merely in relieving symptoms bu...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use